SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
541Chuckle, thanks appreciate the sympathy. time for a pint. hope all is well wmopgcw-4/5/2013
540Sorry.nigel bates-4/5/2013
539arghh.mopgcw-4/5/2013
538"... interesting to see if the P3 yields a better answer next year." nigel bates-4/5/2013
537i guess $9.50 was not too shabby now... it will be interesting to see if the P3mopgcw-12/13/2012
536UPDATE 3-Hopes fade for AstraZeneca and Rigel's arthritis pill10:37 AM ET, 1mopgcw-12/13/2012
535$9.50...that stings.mopgcw-10/3/2012
534prnewswire.commopgcw-9/6/2012
533SOUTH SAN FRANCISCO, Calif., June 19, 2012 /PRNewswire/ -- AstraZeneca and Rigelmopgcw-6/20/2012
532Nope.tuck-4/28/2012
531Tuck, Any update on your search regards syk inhibitor landscape (competitors)?Miljenko Zuanic-4/27/2012
530Competition update from Portola's syk program portola.com >> J Pharmtuck-2/2/2012
52915% move up this week; someone is buying..mopgcw-1/27/2012
528Rigel to Webcast Investor Day on October 13, 2011 Thu October 6, 2011 7:30 AM mopgcw-10/7/2011
527JPMorgan Starts Rigel Pharmaceuticals (RIGL) at Overweight 7:32 am ET 09/29/2011mopgcw-9/29/2011
526is it my mis-read or somebody is accumulating the stock...mopgcw-6/29/2011
525Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With itmopgcw-5/27/2011
524It will not be the first, or the last time that pharma dumped something that wilMiljenko Zuanic-5/10/2011
523Rigel Assumes Development Responsibility for Inhaled Asthma Therapy PR Newswire mopgcw-5/7/2011
522Well, it sounds like PFE hasn't given up on R343 just yet ( siliconinvestormcbio-3/1/2011
521The potential for there being a breast cancer signal with Syk inhibition is realmcbio-2/2/2011
520This is not quite as settled as Peter's post makes it look. See my reply hetuck-2/2/2011
519Good catch. That's a possible buying op in the making. The return of the ptuck-2/2/2011
518Could RIGL's partnership with PFE for R343 be on the chopping block? See: mcbio-2/1/2011
517Hey Tuck, Yeah I do believe you have the takeaway right. In terms of commerciamcbio-2/1/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News